| Screening for engineered neomycin riboswitches that control translation initiation JE Weigand, M Sanchez, EB Gunnesch, S Zeiher, R Schroeder, B Suess Rna 14 (1), 89-97, 2008 | 236 | 2008 |
| Thermodynamic characterization of an engineered tetracycline-binding riboswitch M Müller, JE Weigand, O Weichenrieder, B Suess Nucleic acids research 34 (9), 2607-2617, 2006 | 176 | 2006 |
| Tetracycline aptamer-controlled regulation of pre-mRNA splicing in yeast JE Weigand, B Suess Nucleic acids research 35 (12), 4179-4185, 2007 | 159 | 2007 |
| Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy A Wacker, JE Weigand, SR Akabayov, N Altincekic, JK Bains, ... Nucleic acids research 48 (22), 12415-12435, 2020 | 133 | 2020 |
| Engineered riboswitches: overview, problems and trends B Suess, JE Weigand RNA biology 5 (1), 24-29, 2008 | 118 | 2008 |
| Hypoxia-induced alternative splicing in endothelial cells JE Weigand, JN Boeckel, P Gellert, S Dimmeler Public Library of Science 7 (8), e42697, 2012 | 105 | 2012 |
| Aptamers and riboswitches: perspectives in biotechnology JE Weigand, B Suess Applied microbiology and biotechnology 85, 229-236, 2009 | 104 | 2009 |
| Highly modular structure and ligand binding by conformational capture in a minimalistic riboswitch E Duchardt‐Ferner, JE Weigand, O Ohlenschläger, SR Schmidtke, ... Angewandte Chemie International Edition 35 (49), 6216-6219, 2010 | 101 | 2010 |
| A fast and efficient translational control system for conditional expression of yeast genes P Kötter, JE Weigand, B Meyer, KD Entian, B Suess Nucleic acids research 37 (18), e120-e120, 2009 | 101 | 2009 |
| Mechanistic insights into an engineered riboswitch: a switching element which confers riboswitch activity JE Weigand, SR Schmidtke, TJ Will, E Duchardt-Ferner, C Hammann, ... Nucleic acids research 39 (8), 3363-3372, 2011 | 76 | 2011 |
| Conformational dynamics of the tetracycline-binding aptamer U Förster, JE Weigand, P Trojanowski, B Suess, J Wachtveitl Nucleic acids research 40 (4), 1807-1817, 2012 | 69 | 2012 |
| PELDOR spectroscopy reveals preorganization of the neomycin-responsive riboswitch tertiary structure I Krstic, O Frolow, D Sezer, B Endeward, JE Weigand, B Suess, ... Journal of the American Chemical Society 132 (5), 1454-1455, 2010 | 66 | 2010 |
| Exploring the Druggability of Conserved RNA Regulatory Elements in the SARS‐CoV‐2 Genome S Sreeramulu, C Richter, H Berg, MA Wirtz Martin, B Ceylan, T Matzel, ... Angewandte Chemie 133 (35), 19340-19349, 2021 | 61 | 2021 |
| Ligand-induced conformational capture of a synthetic tetracycline riboswitch revealed by pulse EPR D Wunnicke, D Strohbach, JE Weigand, B Appel, E Feresin, B Suess, ... Rna 17 (1), 182-188, 2011 | 61 | 2011 |
| A small, portable RNA device for the control of exon skipping in mammalian cells M Vogel, JE Weigand, B Kluge, M Grez, B Suess Nucleic acids research 46 (8), e48-e48, 2018 | 50 | 2018 |
| A universal aptamer chimera for the delivery of functional microRNA-126 JH Rohde, JE Weigand, B Suess, S Dimmeler nucleic acid therapeutics 25 (3), 141-151, 2015 | 46 | 2015 |
| What a Difference an OH Makes: Conformational Dynamics as the Basis for the Ligand Specificity of the Neomycin‐Sensing Riboswitch E Duchardt‐Ferner, SR Gottstein‐Schmidtke, JE Weigand, ... Angewandte Chemie International Edition 55 (4), 1527-1530, 2016 | 42 | 2016 |
| Large-scale recombinant production of the SARS-CoV-2 proteome for high-throughput and structural biology applications N Altincekic, SM Korn, NS Qureshi, M Dujardin, M Ninot-Pedrosa, R Abele, ... Frontiers in molecular biosciences, 89, 2021 | 39 | 2021 |
| Auto-and cross-regulation of the hnRNPs D and DL K Kemmerer, S Fischer, JE Weigand Rna 24 (3), 324-331, 2018 | 36 | 2018 |
| Tetracycline determines the conformation of its aptamer at physiological magnesium concentrations AJ Reuss, M Vogel, JE Weigand, B Suess, J Wachtveitl Biophysical journal 107 (12), 2962-2971, 2014 | 36 | 2014 |
